Business
QuidelOrtho Announces New R&D Executive Leader
Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO--(BUSINESS WIRE)-- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative
About this update from Quidelortho Corporation
[{"type":"text","content":"\nJonathan Siegrist appointed as EVP of R&D and CTO\n\n SAN DIEGO--(BUSINESS WIRE)--\nQuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the appointment of Jonathan Siegrist, PhD, as its new Executive Vice President of Research and Development (R&D) and Chief Technology Officer (CTO), effective as of October 7, 2024.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241009251239/en/Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire)\nSiegrist brings a wealth of industry expertise and leadership experience with over 15 years in molecular diagnostics, microfluidic platforms, and biomedical engineering. He most recently was the CTO and Head of Assay Research and Development at Cepheid. Prior to Cepheid, he co-founded a diagnostics manufacturing company.\n\nReporting to Brian Blaser, President and Chief Executive Officer, Siegrist will spearhead QuidelOrtho’s R&D strategy with a focus on menu expansion and advancing critical platforms. His leadership is expected to advance QuidelOrtho’s industry-leading expertise in immunoassay and molecular testing and award-winning solutions in clinical labs and transfusion medicine. Werner Kroll, Senior Vice President, R&D, will support a smooth leadership transition and related activities until his retirement in March 2025.\n\n“QuidelOrtho is at a pivotal point in our history, and Jonathan’s deep industry knowledge and insights in assay R&D and proven leadership make him an excellent fit for this role. We are confident his innovative approach will help us navigate our current opportunities and lead the company to success,” said Brian Blaser, President and Chief Executive Officer, QuidelOrtho.\n\nSiegrist holds a PhD and Master of Science from the University of California, Irvine, and a Bachelor of Science in Electrical Engineering from the University of California, Los Angeles. His career has been marked by successful leadership roles across multiple disciplines within R&D.\n\nQuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit www.quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook, and X.\n\nAbout QuidelOrtho Corporation\n\nQuidelOrtho Corporation (Nasdaq: QDEL) is a world leader ...